SLC9A1 and neoplasm: Di Sario et al., have also shown that cariporide, through its selective inhibition of NHE1 and subsequent decrease of intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells [112], leading these authors to suggest the potential therapeutic value of cariporide against this human tumor.